Related Experiment Video
Updated: Aug 14, 2026
Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
Partial protection against collagen antibody-induced arthritis in PARP-1 deficient mice
Samuel García1, Ana Bodaño, Antonio González
1Research Laboratory, Hospital Clínico Universitario, Choupana s/n, 15706-Santiago de Compostela, Spain. samugp13@yahoo.es
Abstract:
Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear DNA-binding protein that participates in the regulation of DNA repair and maintenance of genomic integrity. In addition, PARP-1 has a role in several models of inflammation disease, where its absence or inactivation confers protection. The aim of this study was to analyze the impact of selective PARP-1 suppression in collagen antibody-induced arthritis. We show that PARP-1 deficiency partially reduces the severity of arthritis, although the incidence of disease was similar in control and deficient mice. Decreased clinical scores were accompanied by partial reduction of histopathological findings. Interestingly, quantitative real-time PCR and ELISA analysis revealed that the absence of PARP-1 down-regulated IL-1beta and monocyte chemotactic protein 1 expression in arthritic joints whereas tumor necrosis factor-alpha transcription was not impaired. Our results provide evidence of the contribution of PARP-1 to the progression of arthritis and identify this protein as a potential therapeutic target for the treatment of rheumatoid arthritis.
Insights
Selective suppression of Poly(ADP-ribose) polymerase-1 (PARP-1) partially reduced arthritis severity in mice. This suggests PARP-1 is a potential therapeutic target for rheumatoid arthritis treatment.
Area of Science:
- Molecular Biology
- Immunology
- Rheumatology
Background:
- Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear protein involved in DNA repair and genomic stability.
- PARP-1 plays a role in inflammatory diseases, with its absence conferring protection.
- Collagen antibody-induced arthritis serves as a model for rheumatoid arthritis.
Purpose of the Study:
- To investigate the impact of selective PARP-1 suppression on collagen antibody-induced arthritis.
- To determine if inhibiting PARP-1 affects arthritis severity and underlying molecular mechanisms.
Main Methods:
- Utilized a mouse model of collagen antibody-induced arthritis.
- Assessed arthritis severity through clinical scores and histopathological analysis.
- Quantified gene expression of inflammatory markers (IL-1beta, MCP-1, TNF-alpha) using quantitative real-time PCR and ELISA.
Main Results:
- PARP-1 deficiency partially reduced the clinical severity of arthritis.
- Histopathological findings were partially ameliorated in PARP-1 deficient mice.
- Absence of PARP-1 down-regulated IL-1beta and monocyte chemotactic protein 1 expression in arthritic joints, but not TNF-alpha.
Conclusions:
- PARP-1 contributes to the progression of collagen antibody-induced arthritis.
- Selective PARP-1 suppression shows potential for mitigating arthritis.
- PARP-1 is identified as a potential therapeutic target for rheumatoid arthritis.
